ArticleJournal of nanobiotechnology2025
USP5 inhibition via bone marrow-targeted engineered exosomes for myeloproliferative neoplasms therapy.
Wenjun Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it